| OSA | Osteosarcoma |
| ICI | Immune checkpoint inhibitors |
| TME | Tumor microenvironment |
| ADC | Antibody–drug conjugates |
| CAR-T | Chimeric antigen receptor-T-cell |
| CSPG4 | Chondroitin sulfate proteoglycan 4 |
| TLR2 | Toll-like receptor 2 |
| ECM | Extracellular matrix |
| TAMs | Tumor-associated macrophages |
| MDSCs | Myeloid-derived suppressor cells |
| MSC | Mesenchymal stem cells |
| NK | Natural killer |
| DCs | Dendritic cells |
| EMT | Epithelial–mesenchymal transition |
| MMP-2 | Matrix metalloproteinase-2 |
| mAbs | Monoclonal antibodies |
| I-DXd | Ifinatamab deruxtecan |
| 2D | Two-dimensional |
| 3D | Three-dimensional |
| NSG | NOD-scid IL2Rγnull |
| scRNA-seq | single-cell RNA sequencing |